Literature DB >> 21166393

StructRank: a new approach for ligand-based virtual screening.

Fabian Rathke1, Katja Hansen, Ulf Brefeld, Klaus-Robert Müller.   

Abstract

Screening large libraries of chemical compounds against a biological target, typically a receptor or an enzyme, is a crucial step in the process of drug discovery. Virtual screening (VS) can be seen as a ranking problem which prefers as many actives as possible at the top of the ranking. As a standard, current Quantitative Structure-Activity Relationship (QSAR) models apply regression methods to predict the level of activity for each molecule and then sort them to establish the ranking. In this paper, we propose a top-k ranking algorithm (StructRank) based on Support Vector Machines to solve the early recognition problem directly. Empirically, we show that our ranking approach outperforms not only regression methods but another ranking approach recently proposed for QSAR ranking, RankSVM, in terms of actives found.

Mesh:

Substances:

Year:  2010        PMID: 21166393     DOI: 10.1021/ci100308f

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  7 in total

1.  Quantum probability ranking principle for ligand-based virtual screening.

Authors:  Mohammed Mumtaz Al-Dabbagh; Naomie Salim; Mubarak Himmat; Ali Ahmed; Faisal Saeed
Journal:  J Comput Aided Mol Des       Date:  2017-02-20       Impact factor: 3.686

2.  Ranking-Oriented Quantitative Structure-Activity Relationship Modeling Combined with Assay-Wise Data Integration.

Authors:  Katsuhisa Matsumoto; Tomoyuki Miyao; Kimito Funatsu
Journal:  ACS Omega       Date:  2021-04-28

3.  MLViS: A Web Tool for Machine Learning-Based Virtual Screening in Early-Phase of Drug Discovery and Development.

Authors:  Selcuk Korkmaz; Gokmen Zararsiz; Dincer Goksuluk
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

4.  When drug discovery meets web search: Learning to Rank for ligand-based virtual screening.

Authors:  Wei Zhang; Lijuan Ji; Yanan Chen; Kailin Tang; Haiping Wang; Ruixin Zhu; Wei Jia; Zhiwei Cao; Qi Liu
Journal:  J Cheminform       Date:  2015-02-13       Impact factor: 5.514

5.  A ranking method for the concurrent learning of compounds with various activity profiles.

Authors:  Alexander Dörr; Lars Rosenbaum; Andreas Zell
Journal:  J Cheminform       Date:  2015-01-16       Impact factor: 5.514

6.  DrugE-Rank: improving drug-target interaction prediction of new candidate drugs or targets by ensemble learning to rank.

Authors:  Qingjun Yuan; Junning Gao; Dongliang Wu; Shihua Zhang; Hiroshi Mamitsuka; Shanfeng Zhu
Journal:  Bioinformatics       Date:  2016-06-15       Impact factor: 6.937

Review 7.  The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions.

Authors:  Rameez Hassan Pirzada; Nasir Javaid; Sangdun Choi
Journal:  Genes (Basel)       Date:  2020-01-27       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.